demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 outpatients
antiandrogenic
dutasteride Cadegiani ...

2 studies excluded by filtering options 2

6371 McCoy, 2020 212excluded
7998 Cadegiani (female patients), 2021 213excludedhigh risk of bias